MedTrace Logo

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

NCT00206908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2015-07-22

No results posted yet for this study

Summary

This project is designed to evaluate the clinical utility of a novel blood test, the Triage Stroke Panel, as an aid in the diagnosis and assessment of stroke. The Triage Stroke Panel test device, used with the Triage MeterPlus, is a rapid, point-of-care immunoassay. The test measures the concentration of various analytes present in EDTA-anticoagulated whole blood or plasma, specifically B-type natriuretic peptide (BNP), fibrin degradation products containing D-Dimer, matrix metalloproteiase-9 (MMP-9), and S-100B. The test utilizes a proprietary algorithm for the automatic calculation of a single Multimarker Index (MMX) result from the individual biomarker values. The MMX result is being evaluated for use as an aid in the assessment and diagnosis of stroke.

Conditions

  • Stroke
  • Stroke Mimic(Conditions Presenting With Stroke-like Conditions)

Sponsors & Collaborators

  • Abbott RDx Cardiometabolic

    lead OTHER

Principal Investigators

  • Daniel Laskowitz, MD · Duke University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31

Countries

  • United States
  • Canada
  • Germany
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00206908 on ClinicalTrials.gov